Compounding Pharmacy Education — 503A vs 503B, USP Standards, Accreditation

Pharmacy Education Center

Everything Providers Need to Know About
Compounding Pharmacy

503A vs 503B, sterile compounding, USP standards, accreditation, FDA compliance, and how to evaluate a pharmacy for your practice — the complete provider guide.

What this page coversCompounding pharmacy education for healthcare providers covers: the 503A vs 503B distinction (patient-specific vs. office-use compounding), sterile vs. non-sterile compounding requirements, USP <795>, <797>, and <800> standards, PCAB and ACHC accreditation, and a 7-step pharmacy evaluation checklist. Essential reading before establishing any compounding pharmacy relationship.
Who this is for: Physicians, NPs, PAs, clinic owners, telehealth operators, hormone clinic directors, and any healthcare provider prescribing or considering compounded medications.
Disclaimer: Compounding pharmacy regulations, FDA guidance, and USP standards change frequently. This guide is for educational purposes. Verify current requirements with your state board of pharmacy, a healthcare attorney, and the pharmacy directly before prescribing compounded medications.

What Is Pharmaceutical Compounding?

Quick answer: Pharmaceutical compounding is the preparation of a customized medication for an individual patient when a commercially available drug does not meet their specific needs.

Pharmaceutical compounding is the process of creating a customized medication for an individual patient when a commercially available drug does not meet their specific needs. A licensed pharmacist or physician combines, mixes, or alters ingredients to create a medication tailored to the patient's requirements — such as a different strength, dosage form, or the removal of a non-essential ingredient like a dye or preservative.

Compounding has been practiced for centuries and remains an essential part of modern healthcare, particularly for patients with unique clinical needs, allergies, or conditions requiring specialized formulations. Today, compounding is widely used in hormone therapy, peptide medicine, pain management, dermatology, veterinary medicine, and pediatrics.

When is compounding appropriate?

  • Patient requires a dosage form not commercially available (e.g., topical instead of oral)
  • Patient has an allergy to an inactive ingredient in the commercial product
  • Patient requires a strength not commercially available
  • Commercial product is on FDA drug shortage list
  • Patient requires a combination of medications not available commercially
  • Pediatric patient requires a lower dose or more palatable formulation

503A vs. 503B: The Critical Distinction

Quick answer: 503A pharmacies compound for individual patients with a prescription. 503B outsourcing facilities compound in bulk for healthcare facilities without patient-specific prescriptions — and are FDA-registered and inspected.

The 503A/503B distinction is the most important regulatory framework for providers prescribing compounded medications. Understanding this distinction affects how you order, what you can order, and what regulatory standards apply.

Dimension503A Pharmacy503B Outsourcing Facility
Regulatory oversightState board of pharmacy (primary)FDA + state board of pharmacy
Prescription requirementPatient-specific prescription requiredCan compound without patient-specific Rx for office use
VolumeLimited quantities for individual patientsLarge-scale production for healthcare facilities
Quality standardsUSP <795>, <797>, <800>cGMP (similar to pharmaceutical manufacturers)
FDA registrationNot requiredRequired — FDA-registered and inspected
AccreditationPCAB or ACHC (voluntary)FDA inspection (mandatory)
Common useIndividual patient prescriptionsOffice-use stock, hospital formularies
ExamplesMost local and mail-order compounding pharmaciesEmpower Pharmacy, Olympia Pharmacy, Fagron Sterile Services

Sterile vs. Non-Sterile Compounding

The sterile/non-sterile distinction determines the level of facility requirements, personnel training, and quality standards required for a compounding preparation.

Sterile compounding involves the preparation of medications that must be free from microorganisms and particulate matter — including injectables, IV preparations, eye drops, and certain nasal sprays. Sterile compounding requires specialized cleanroom facilities, laminar airflow hoods, and rigorous environmental monitoring. Must comply with USP <797>.

Non-sterile compounding involves the preparation of medications that do not require sterility — such as topical creams, gels, capsules, troches, and oral suspensions. Non-sterile compounding requires a clean, controlled environment but not a sterile cleanroom. Must comply with USP <795>.

Why this matters for providers: When ordering injectable medications (peptides, hormones, vitamins), always verify that the pharmacy has sterile compounding capabilities and USP <797> compliance. Ordering injectables from a non-sterile pharmacy is a serious patient safety risk.

Patient Safety: Never order injectable medications from a pharmacy that cannot document USP <797> compliance and sterility testing. Contaminated injectables have caused patient deaths and led to major FDA enforcement actions.

Schedule a Healthcare Strategy Session

Get Started

USP Standards: 795, 797, and 800

Quick answer: USP <795> governs non-sterile compounding. USP <797> governs sterile compounding. USP <800> governs hazardous drug handling. All three are enforced by state boards of pharmacy.

The United States Pharmacopeia (USP) establishes the quality standards that compounding pharmacies must follow. Three chapters are most relevant for providers prescribing compounded medications:

USP ChapterScopeKey RequirementsWho It Applies To
USP <795>Non-sterile compoundingBeyond-use dating, labeling, quality controls, environmental monitoringAll pharmacies doing non-sterile compounding
USP <797>Sterile compoundingCleanroom requirements, personnel training, environmental monitoring, sterility testing, BUDsAll pharmacies doing sterile compounding (injectables, eye drops, IV)
USP <800>Hazardous drug handlingFacility requirements, PPE, containment, disposal, personnel trainingAny facility handling hazardous drugs (chemo, certain hormones, some antifungals)
USP <1> through <1999>General standardsTesting methods, reference standards, general informationAll pharmacies and pharmaceutical manufacturers

PCAB and ACHC Accreditation: What They Mean

Pharmacy accreditation is a voluntary quality designation that indicates a compounding pharmacy has been independently evaluated against rigorous standards. While not legally required in most states, accreditation is a strong indicator of pharmacy quality and is increasingly expected by healthcare providers.

PCAB (Pharmacy Compounding Accreditation Board) is the most recognized accreditation specifically for compounding pharmacies. PCAB-accredited pharmacies undergo regular on-site inspections and must demonstrate adherence to USP standards, proper documentation, and quality assurance processes. PCAB is widely considered the gold standard for compounding accreditation.

ACHC (Accreditation Commission for Health Care) offers broader healthcare accreditation including compounding pharmacy. ACHC accreditation is also recognized as an indicator of quality.

How to verify accreditation:

  • PCAB accreditation: verify at pcab.org — search by pharmacy name
  • ACHC accreditation: verify at achc.org — search by organization name
  • FDA 503B registration: verify at accessdata.fda.gov/scripts/fdcc/?set=outsourcingfacilities
  • State pharmacy license: verify at your state board of pharmacy website
  • NABP e-Profile: verify at nabp.pharmacy

How to Evaluate a Compounding Pharmacy: 7-Step Checklist

Quick answer: Before establishing a relationship with any compounding pharmacy, verify state licensure, NABP status, accreditation, FDA registration (503B), USP compliance, certificates of analysis, and shipping capabilities.

Before establishing a relationship with a compounding pharmacy, healthcare providers should conduct thorough due diligence. This 7-step checklist covers the essential verification steps:

  • State licensure — Verify active license with the relevant state board of pharmacy. Check for any disciplinary actions or license restrictions.
  • NABP e-Profile — Check the pharmacy's NABP e-Profile at nabp.pharmacy for compliance history.
  • PCAB or ACHC accreditation — Verify accreditation status at pcab.org or achc.org. Accreditation indicates independent quality inspection.
  • FDA registration (503B only) — For outsourcing facilities, verify FDA registration and review inspection history at accessdata.fda.gov.
  • USP compliance documentation — Request documentation of USP <795> and <797> compliance. For sterile preparations, request environmental monitoring data and sterility testing results.
  • Certificates of analysis — Request COAs for the specific preparations you plan to order. COAs should confirm identity, potency, purity, and sterility from an independent laboratory.
  • Shipping capabilities — Confirm the pharmacy is licensed to ship to your state and has appropriate cold-chain shipping for temperature-sensitive preparations.

Need a Medical Director?

Get Started

FDA Compliance and the Regulatory Landscape

The FDA's oversight of compounding pharmacy has increased significantly since the 2012 New England Compounding Center (NECC) meningitis outbreak that killed 64 patients. The Drug Quality and Security Act (DQSA) of 2013 created the 503B outsourcing facility category and gave the FDA clearer authority over large-scale compounding.

Key FDA compliance areas for providers:

Drug shortage compounding: 503A pharmacies may compound copies of FDA-approved drugs when the drug is on the FDA shortage list. Verify current shortage status at accessdata.fda.gov/scripts/drugshortages/ before prescribing compounded versions of commercial drugs.

Bulk drug substance lists: The FDA maintains lists of bulk drug substances that may (Category 1) and may not (Category 2) be used in compounding. Verify the status of any bulk drug substance before prescribing.

FDA warning letters: The FDA publishes warning letters to compounding pharmacies that violate regulations. Review FDA warning letters at fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters before establishing a relationship with any pharmacy.

Due Diligence: Search for your pharmacy's name in the FDA warning letter database before ordering. A recent warning letter is a serious red flag that should prompt additional scrutiny or selection of an alternative pharmacy.

Build the infrastructure behind your clinic.

AJ Pakpour advises physicians, NPs, PAs, clinic owners, and healthcare entrepreneurs on compliance, operations, and growth.

Frequently Asked Questions

Can a 503A pharmacy compound GLP-1 medications?

A 503A pharmacy may compound GLP-1 medications such as semaglutide or tirzepatide for individual patients based on a valid prescription when the drug is on the FDA's drug shortage list or when a patient has a documented clinical need that cannot be met by commercially available products. Providers should verify current FDA guidance and the pharmacy's compliance status.

What is the difference between compounded and FDA-approved medications?

FDA-approved medications have undergone rigorous clinical trials to demonstrate safety and efficacy. Compounded medications are not FDA-approved but are prepared by licensed pharmacists for individual patient needs. Compounding pharmacies must follow USP standards and state regulations, but compounded medications do not go through the same approval process as commercial drugs.

Are compounded medications covered by insurance?

Coverage for compounded medications varies by insurance plan. Many compounded medications are not covered by commercial insurance or Medicare/Medicaid. Patients typically pay out-of-pocket for compounded medications. Some pharmacies offer cash-pay pricing programs.

What is a beyond-use date (BUD)?

A beyond-use date is the date after which a compounded preparation should not be used. BUDs are assigned by the compounding pharmacist based on USP standards, the nature of the ingredients, and storage conditions. BUDs are different from expiration dates on commercially manufactured drugs.

What is PCAB accreditation?

PCAB (Pharmacy Compounding Accreditation Board) accreditation is a voluntary quality designation that indicates a compounding pharmacy meets rigorous standards for safety, quality, and compliance. PCAB-accredited pharmacies undergo regular on-site inspections and must demonstrate adherence to USP standards, proper documentation, and quality assurance processes.

What is USP 800 and who does it apply to?

USP <800> addresses the safe handling of hazardous drugs in healthcare settings, including compounding pharmacies. It establishes requirements for facilities, equipment, personnel training, and disposal of hazardous drugs to protect healthcare workers and patients. It applies to any facility that handles hazardous drugs — not just compounding pharmacies.

Can a 503B outsourcing facility compound without a prescription?

Yes. 503B outsourcing facilities can compound medications in larger quantities for healthcare facilities and providers without patient-specific prescriptions. They are FDA-registered and inspected, and must comply with cGMP standards. 503B facilities are commonly used by clinics and hospitals that need office-use quantities of compounded medications.

How do I verify a compounding pharmacy's license?

Verify a compounding pharmacy's license through the relevant state board of pharmacy. For 503B outsourcing facilities, verify FDA registration at accessdata.fda.gov. For PCAB accreditation, verify at pcab.org. For ACHC accreditation, verify at achc.org.

What is a certificate of analysis (COA) and should I request one?

A certificate of analysis (COA) is a document from an independent laboratory confirming the identity, potency, purity, and sterility of a compounded preparation. Reputable compounding pharmacies provide COAs for their preparations upon request. Always request a COA for injectable preparations and high-risk compounds.

What is the difference between PCAB and ACHC accreditation?

PCAB (Pharmacy Compounding Accreditation Board) focuses specifically on compounding pharmacy quality and is widely recognized as the gold standard for compounding accreditation. ACHC (Accreditation Commission for Health Care) offers broader healthcare accreditation including compounding pharmacy. Both are recognized indicators of quality — PCAB is more specific to compounding.

Browse Pharmacy Directory Compounding Pharmacy Services